SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2179011

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2179011

CRISPR Crop Trait Development Platforms Market Forecasts to 2034 - Global Analysis By Editing Technology (CRISPR-Cas9, CRISPR-Cas12, Base Editing, and Prime Editing), Platform Component, Crop Trait, Application, End User, and By Geography

PUBLISHED:
PAGES: 300+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global CRISPR Crop Trait Development Platforms Market is accounted for $0.7 billion in 2026 and is expected to reach $2.6 billion by 2034 growing at a CAGR of 17.8% during the forecast period. CRISPR crop trait development platforms are integrated systems that design, deliver, and validate precise genomic edits in crop plants. Editing technologies include CRISPR-Cas9, CRISPR-Cas12, base editing, and prime editing, supported by guide RNA design software, delivery systems, screening and validation workflows, and trait discovery tools. Platforms introduce targeted changes such as disease resistance, drought tolerance, yield enhancement, and nutritional quality without retaining foreign DNA. Outputs are validated breeding lines and licensed trait intellectual property.

Market Dynamics:

Driver:

Precision Breeding Regulatory Pathways

Growing acceptance of precision breeding frameworks in several jurisdictions is driving investment in CRISPR trait platforms, because edited crops that contain no foreign DNA can clear review faster than transgenic events. Developers gain earlier market access and shorter payback periods on research spending. Regulatory clarity reduces commercial risk and attracts capital. This policy shift supports platform licensing revenue and trait royalty models across seed companies and research institutions in approving markets.

Restraint:

Genotype Dependence and Delivery Limits

Editing efficiency varies substantially by crop genotype, and many elite varieties regenerate poorly from tissue culture, which slows trait introgression into commercial germplasm. Delivery remains difficult in crops recalcitrant to transformation, and off-target edits require extensive validation. These biological constraints extend development timelines by years and increase costs, confining near-term commercialization to crops with established transformation protocols.

Opportunity:

Nutritional Quality Traits

Nutritional quality traits create substantial opportunity for platform providers to deliver consumer-facing benefits that command premium pricing and attract regulatory support. Edited traits that reduce acrylamide precursors, improve oil composition, or raise micronutrient density appeal to food manufacturers and public health programmes. Consumer acceptance tends to be higher for nutritional benefit than for agronomic traits. As frameworks mature, nutritional quality can capture premium royalties across food value chains.

Threat:

Substitution by Conventional Breeding

Conventional breeding and marker-assisted selection remain inexpensive, widely accepted, and free of regulatory review, which reduces willingness to invest in editing platforms for traits that can be developed through crossing. Many breeding programmes perceive established methods as sufficient for incremental gains. If genomic selection accelerates conventional programmes further, editing may remain confined to traits that cannot be achieved by existing variation. Consequently, platforms must demonstrate unique trait value.

Covid-19 Impact:

The pandemic closed laboratories and delayed field trials while restricting movement of plant material between research sites. During the crisis, breeding programmes extended timelines and prioritised existing pipelines over new trait development. Post-pandemic, restored research capacity and expanding regulatory clarity have accelerated editing programmes, while platform providers advanced transformation protocols and validation throughput.

The CRISPR-Cas9 segment is expected to be the largest during the forecast period

The CRISPR-Cas9 segment is expected to account for the largest market share during the forecast period, due to its maturity, extensive published validation across major crops, and broad availability of reagents and protocols. Cas9 remains the reference platform for most commercial trait programmes. Established licensing frameworks simplify deployment. As new editing modalities emerge, Cas9 continues to anchor development pipelines, thereby sustaining leading revenue share across the category.

The Delivery Systems segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Delivery Systems segment is predicted to witness the highest growth rate, driven by recognition that transformation and regeneration bottlenecks, rather than editing chemistry, now limit crop trait development. Advances in nanoparticle delivery, meristem targeting, and regeneration-boosting treatments address this constraint directly. As these methods mature, delivery systems accelerate faster than guide RNA design, screening, and trait discovery software segments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to favourable precision breeding policy, strong venture funding for agricultural biotechnology, and concentration of leading seed companies and research institutions. The United States dominates regional revenue, supported by trait development programmes across corn, soy, and specialty crops. Established intellectual property frameworks further reinforce the region's leading position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding public research investment, evolving regulatory frameworks in China, Japan, and India, and growing demand for climate-resilient varieties. Local institutions advance transformation protocols for rice, wheat, and horticultural crops. Improving public-private partnerships further support adoption, making Asia Pacific the fastest-growing regional market.

Key players in the market

Some of the key players in CRISPR Crop Trait Development Platforms Market include Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., FMC Corporation, UPL Limited, Novonesis A/S, Koppert Biological Systems, Bioceres Crop Solutions Corp., Valent BioSciences LLC, Lallemand Inc., Marrone Bio Innovations, Pivot Bio, Indigo Ag, Ginkgo Bioworks, and Verdesian Life Sciences.

Key Developments:

In October 2026, Corteva, Inc. launched a base editing platform module targeting drought tolerance in cereals, offered through licensing partnerships with seed companies across North American and Latin American markets.

In September 2026, Syngenta Group expanded its trait development portfolio with prime editing delivery protocols for vegetable crops, deployed through research collaborations across European and Asian breeding programmes.

In August 2026, BASF SE introduced a guide RNA design and trait discovery software suite supporting multi-crop editing workflows, distributed through platform licensing agreements across global seed and research partners.

Editing Technologies Covered:

  • CRISPR-Cas9
  • CRISPR-Cas12
  • Base Editing
  • Prime Editing

Platform Components Covered:

  • Guide RNA Design
  • Delivery Systems
  • Screening and Validation
  • Trait Discovery Software

Crop Traits Covered:

  • Disease Resistance
  • Drought Tolerance
  • Yield Enhancement
  • Nutritional Quality

Applications Covered:

  • Cereals and Grains
  • Fruits and Vegetables
  • Oilseeds and Pulses
  • Commercial Horticulture

End Users Covered:

  • Commercial Farms
  • Greenhouse Operators
  • Agricultural Input Manufacturers
  • Research Institutions
  • Agricultural Service Providers

Regions Covered:

North America

United States

Canada

Mexico

Europe

United Kingdom

Germany

France

Italy

Spain

Netherlands

Belgium

Sweden

Switzerland

Poland

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Thailand

Malaysia

Singapore

Vietnam

Rest of Asia Pacific

South America

Brazil

Argentina

Colombia

Chile

Peru

Rest of South America

Rest of the World (RoW)

Middle East

Saudi Arabia

United Arab Emirates

Qatar

Israel

Rest of Middle East

Africa

South Africa

Egypt

Morocco

Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling

Comprehensive profiling of additional market players (up to 3)

SWOT Analysis of key players (up to 3)

Regional Segmentation

Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)

Competitive Benchmarking

    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC41614

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global CRISPR Crop Trait Development Platforms Market, By Editing Technology

  • 5.1 CRISPR-Cas9
  • 5.2 CRISPR-Cas12
  • 5.3 Base Editing
  • 5.4 Prime Editing

6 Global CRISPR Crop Trait Development Platforms Market, By Platform Component

  • 6.1 Guide RNA Design
  • 6.2 Delivery Systems
  • 6.3 Screening and Validation
  • 6.4 Trait Discovery Software

7 Global CRISPR Crop Trait Development Platforms Market, By Crop Trait

  • 7.1 Disease Resistance
  • 7.2 Drought Tolerance
  • 7.3 Yield Enhancement
  • 7.4 Nutritional Quality

8 Global CRISPR Crop Trait Development Platforms Market, By Application

  • 8.1 Cereals and Grains
  • 8.2 Fruits and Vegetables
  • 8.3 Oilseeds and Pulses
  • 8.4 Commercial Horticulture

9 Global CRISPR Crop Trait Development Platforms Market, By End User

  • 9.1 Commercial Farms
  • 9.2 Greenhouse Operators
  • 9.3 Agricultural Input Manufacturers
  • 9.4 Research Institutions
  • 9.5 Agricultural Service Providers

10 Global CRISPR Crop Trait Development Platforms Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiling

  • 13.1 Bayer AG
  • 13.2 BASF SE
  • 13.3 Syngenta Group
  • 13.4 Corteva, Inc.
  • 13.5 FMC Corporation
  • 13.6 UPL Limited
  • 13.7 Novonesis A/S
  • 13.8 Koppert Biological Systems
  • 13.9 Bioceres Crop Solutions Corp.
  • 13.10 Valent BioSciences LLC
  • 13.11 Lallemand Inc.
  • 13.12 Marrone Bio Innovations
  • 13.13 Pivot Bio
  • 13.14 Indigo Ag
  • 13.15 Ginkgo Bioworks
  • 13.16 Verdesian Life Sciences
Product Code: SMRC41614

List of Tables

  • Table 1 Global CRISPR Crop Trait Development Platforms Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global CRISPR Crop Trait Development Platforms Market Outlook, By Editing Technology (2023-2034) ($MN)
  • Table 3 Global CRISPR Crop Trait Development Platforms Market Outlook, By CRISPR-Cas9 (2023-2034) ($MN)
  • Table 4 Global CRISPR Crop Trait Development Platforms Market Outlook, By CRISPR-Cas12 (2023-2034) ($MN)
  • Table 5 Global CRISPR Crop Trait Development Platforms Market Outlook, By Base Editing (2023-2034) ($MN)
  • Table 6 Global CRISPR Crop Trait Development Platforms Market Outlook, By Prime Editing (2023-2034) ($MN)
  • Table 7 Global CRISPR Crop Trait Development Platforms Market Outlook, By Platform Component (2023-2034) ($MN)
  • Table 8 Global CRISPR Crop Trait Development Platforms Market Outlook, By Guide RNA Design (2023-2034) ($MN)
  • Table 9 Global CRISPR Crop Trait Development Platforms Market Outlook, By Delivery Systems (2023-2034) ($MN)
  • Table 10 Global CRISPR Crop Trait Development Platforms Market Outlook, By Screening and Validation (2023-2034) ($MN)
  • Table 11 Global CRISPR Crop Trait Development Platforms Market Outlook, By Trait Discovery Software (2023-2034) ($MN)
  • Table 12 Global CRISPR Crop Trait Development Platforms Market Outlook, By Crop Trait (2023-2034) ($MN)
  • Table 13 Global CRISPR Crop Trait Development Platforms Market Outlook, By Disease Resistance (2023-2034) ($MN)
  • Table 14 Global CRISPR Crop Trait Development Platforms Market Outlook, By Drought Tolerance (2023-2034) ($MN)
  • Table 15 Global CRISPR Crop Trait Development Platforms Market Outlook, By Yield Enhancement (2023-2034) ($MN)
  • Table 16 Global CRISPR Crop Trait Development Platforms Market Outlook, By Nutritional Quality (2023-2034) ($MN)
  • Table 17 Global CRISPR Crop Trait Development Platforms Market Outlook, By Application (2023-2034) ($MN)
  • Table 18 Global CRISPR Crop Trait Development Platforms Market Outlook, By Cereals and Grains (2023-2034) ($MN)
  • Table 19 Global CRISPR Crop Trait Development Platforms Market Outlook, By Fruits and Vegetables (2023-2034) ($MN)
  • Table 20 Global CRISPR Crop Trait Development Platforms Market Outlook, By Oilseeds and Pulses (2023-2034) ($MN)
  • Table 21 Global CRISPR Crop Trait Development Platforms Market Outlook, By Commercial Horticulture (2023-2034) ($MN)
  • Table 22 Global CRISPR Crop Trait Development Platforms Market Outlook, By End User (2023-2034) ($MN)
  • Table 23 Global CRISPR Crop Trait Development Platforms Market Outlook, By Commercial Farms (2023-2034) ($MN)
  • Table 24 Global CRISPR Crop Trait Development Platforms Market Outlook, By Greenhouse Operators (2023-2034) ($MN)
  • Table 25 Global CRISPR Crop Trait Development Platforms Market Outlook, By Agricultural Input Manufacturers (2023-2034) ($MN)
  • Table 26 Global CRISPR Crop Trait Development Platforms Market Outlook, By Research Institutions (2023-2034) ($MN)
  • Table 27 Global CRISPR Crop Trait Development Platforms Market Outlook, By Agricultural Service Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!